Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CAI FY 2022 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$258M

Gross Profit

$80M31.0% margin

Operating Income

-$316M-122.2% margin

Net Income

-$321M-124.1% margin

EPS (Diluted)

$-1.57

Cash Flow

Operating Cash Flow

-$286M

Free Cash Flow

-$328M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$717M

Total Liabilities

$2.4B

Stockholders' Equity

-$1.7B

Cash & Equivalents

$107M

← Q3 2021 All Quarters FY 2023 →